Levy, Moshe; Rizansky, Adi - In: The European Journal of Health Economics 15 (2014) 2, pp. 143-156
Allowing patients to take part in the initial investment for the development of cures for their illnesses can, under certain conditions, lead to the development of drugs that would have otherwise not been developed and to a dramatic welfare increase. We theoretically analyze these conditions....